Funding in, findings out
For any dataset: the NCI award that paid to create it, and the awards that got a published finding out of it afterwards.
TARGET-CCSK
Clear Cell Sarcoma of the Kidney
0 awards paid to create it · 17 awards funded work that used it
1. Awards that paid to create this data
2. The dataset
3. Articles that used it (5)
4. Awards those articles were funded by (6 of 17)
- Antitumor Assessment · Elisa de Stanchina, FRANCESCA M GANY · FY1985–2026funded 1 of these 5 articles
- Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabiliti… · Marc Ladanyi, SAMUEL SINGER · FY2018–2025funded 1 of these 5 articles
- Pathogenic role of human papillomavirus (HPV) DNA Integration and clonal expans… · Anne Van Arsdale · FY2022–2026funded 1 of these 5 articles
- Open Software and Resource Development Leveraging Next-gen Sequencing Data to F… · Brian Haas · FY2016–2020funded 1 of these 5 articles
- Trinity: Transcriptome assembly for genetic and functional analysis of cancer · Brian Haas, Eric Banks · FY2013–2022funded 1 of these 5 articles
- The Integrative Genomics Viewer (IGV) for Cancer Research · JILL P. MESIROV, James Thomas Robinson · FY2021–2025funded 1 of these 5 articles
The best connected are shown.
Why one side of this chain is empty
- No repository or reviewer names this dataset's marker paper, so no award can be credited with creating it.
Awards that funded work using this data
5 of 10 traced articles report an NCI award.
| Award | Project | Articles it is credited on | Evidence |
|---|---|---|---|
| P30CA008748 P30FY1985–2026$718.2M | Antitumor Assessment | API | |
| P50CA217694 P50FY2018–2025$33.2M | Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial Sarcoma | API | |
| K08CA273527 K08FY2022–2026$1.3M | Pathogenic role of human papillomavirus (HPV) DNA Integration and clonal expansion in cervical tumorigenesis | API | |
| R50CA211461 R50FY2016–2020$1.7M | Open Software and Resource Development Leveraging Next-gen Sequencing Data to Facilitate Computational Analysis of Cancer Biology | API | |
| U24CA180922 U24FY2013–2022$7.5M | Trinity: Transcriptome assembly for genetic and functional analysis of cancer | API | |
| U24CA258406 U24FY2021–2025$4.4M | The Integrative Genomics Viewer (IGV) for Cancer Research | API | |
| P30CA060553 P30FY1993–2026$274.1M | Cancer Center Administration | API | |
| U01CA088131 U01FY2001–2006$1.7M | CATEGORIZATION OF WILMS TUMOR BY GENETIC EXPRESSION | API | |
| U10CA042326 U10FY1985–2003$12.0M | NATIONAL WILMS TUMOR STUDY -5 | API | |
| U10CA098543 U10FY2003–2013$335.5M | Children's Oncology Group Chair's Grant | API | |
| U24CA114766 U24FY2005–2014$14.5M | Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB) | API | |
| P30CA142543 P30FY2010–2026$97.7M | UT Southwestern Medical Center Simmons Comprehensive Cancer Center | API | |
| R01CA272872 R01FY2022–2026$2.1M | Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets | API | |
| T32CA269052 T32FY2022–2026$1.8M | Training Program in Basic and Translational Pediatric Oncology Research | API | |
| P30CA044579 P30FY1987–2026$135.1M | BSR - SR Component | API | |
| R01CA178393 R01FY2016–2026$6.5M | Genomic Architecture of LGL Leukemia | API | |
| R15CA252996 R15FY2020$428k | Disrupting two cancer hallmarks with one target: DHX36, the major G-quadruplex helicase | API |
Awards that maintain or redistribute this data
Resource and center grants credited on articles that used the data. Kept out of the flow above because they pay for the pipes, not for a cohort or a finding.
| Award | Project | Evidence |
|---|---|---|
| P30CA008748 P30FY1985–2026$718.2M | Antitumor Assessment | API |
| P30CA044579 P30FY1987–2026$135.1M | BSR - SR Component | API |
| P30CA060553 P30FY1993–2026$274.1M | Cancer Center Administration | API |
| P30CA142543 P30FY2010–2026$97.7M | UT Southwestern Medical Center Simmons Comprehensive Cancer Center | API |
| P50CA217694 P50FY2018–2025$33.2M | Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial Sarcoma | API |
| U01CA088131 U01FY2001–2006$1.7M | CATEGORIZATION OF WILMS TUMOR BY GENETIC EXPRESSION | API |
| U10CA042326 U10FY1985–2003$12.0M | NATIONAL WILMS TUMOR STUDY -5 | API |
| U10CA098543 U10FY2003–2013$335.5M | Children's Oncology Group Chair's Grant | API |
| U24CA114766 U24FY2005–2014$14.5M | Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB) | API |
| U24CA180922 U24FY2013–2022$7.5M | Trinity: Transcriptome assembly for genetic and functional analysis of cancer | API |
| U24CA258406 U24FY2021–2025$4.4M | The Integrative Genomics Viewer (IGV) for Cancer Research | API |
Where the links come from
NIH RePORTER maps a PMID to the awards that reported it. On a dataset’s marker paper that gives the awards which created it; on an article that used the data, the awards which funded that use.
The two sides are not measured alike. Generation is complete: a dataset has one marker paper and every award on it is resolved. Reuse is a sample - the articles using a dataset can number in the thousands, and only the few dozen strongest are retrieved and looked up. Every award shown here funded reuse; there are more that are not shown.
How far it reaches
283 datasets have an award credited with creating them, 80 with using them, and 31 both.
What is missing
No citable accession means no traceable articles; no authoritative marker paper means no attributable generation award. Absence is a gap in the record. Methods.
Start from an award instead, and see every dataset it touches.